Literature DB >> 21345621

Pretreatment predictors of adverse radiation effects after radiosurgery for arteriovenous malformation.

Caroline Hayhurst1, Eric Monsalves, Monique van Prooijen, Michael Cusimano, May Tsao, Cynthia Menard, Abhaya V Kulkarni, Michael Schwartz, Gelareh Zadeh.   

Abstract

PURPOSE: To identify vascular and dosimetric predictors of symptomatic T2 signal change and adverse radiation effects after radiosurgery for arteriovenous malformation, in order to define and validate preexisting risk models. METHODS AND MATERIALS: A total of 125 patients with arteriovenous malformations (AVM) were treated at our institution between 2005 and 2009. Eighty-five patients have at least 12 months of clinical and radiological follow-up. Any new-onset headaches, new or worsening seizures, or neurological deficit were considered adverse events. Follow-up magnetic resonance images were assessed for new onset T2 signal change and the volume calculated. Pretreatment characteristics and dosimetric variables were analyzed to identify predictors of adverse radiation effects.
RESULTS: There were 19 children and 66 adults in the study cohort, with a mean age of 34 (range 6-74). Twenty-three (27%) patients suffered adverse radiation effects (ARE), 9 patients with permanent neurological deficit (10.6%). Of these, 5 developed fixed visual field deficits. Target volume and 12 Gy volume were the most significant predictors of adverse radiation effects on univariate analysis (p < 0.001). Location and cortical eloquence were not significantly associated with the development of adverse events (p = 0.12). No additional vascular parameters were identified as predictive of ARE. There was a significant target volume threshold of 4 cm(3), above which the rate of ARE increased dramatically. Multivariate analysis target volume and the absence of prior hemorrhage are the only significant predictors of ARE. The volume of T2 signal change correlates to ARE, but only target volume is predictive of a higher volume of T2 signal change.
CONCLUSIONS: Target volume and the absence of prior hemorrhage is the most accurate predictor of adverse radiation effects and complications after radiosurgery for AVMs. A high percentage of permanent visual field defects in this series suggest the optic radiation is a critical radiosensitive structure. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21345621     DOI: 10.1016/j.ijrobp.2010.12.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury.

Authors:  I A Cetin; R Ates; J Dhaens; G Storme
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

2.  Late clinical and radiological complications of stereotactical radiosurgery of arteriovenous malformations of the brain.

Authors:  Vera Parkhutik; Aida Lago; Fernando Aparici; Juan Francisco Vazquez; Jose Ignacio Tembl; Lourdes Guillen; Esperanza Mainar; Victor Vazquez
Journal:  Neuroradiology       Date:  2012-11-27       Impact factor: 2.804

3.  Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation.

Authors:  Paulo L Moraes; Rodrigo S Dias; Eduardo Weltman; Adelmo J Giordani; Salomon Benabou; Helena R C Segreto; Roberto A Segreto
Journal:  Surg Neurol Int       Date:  2015-06-04

4.  Predictive Factors of Radiation-Induced Changes Following Single-Session Gamma Knife Radiosurgery for Arteriovenous Malformations.

Authors:  Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Jong Hee Chang; Jin Woo Chang; Hyun Ho Jung
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

5.  Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution.

Authors:  Sławomir Blamek; Dawid Larysz; Leszek Miszczyk
Journal:  Childs Nerv Syst       Date:  2012-12-08       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.